Russell Investments Group
KALV

Russell Investments Group’s KalVista Pharmaceuticals KALV Stock Holding History

Russell Investments Group’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
56,192
-57
-0.1% -$919 ﹤0.01% 2155
2025
Q4 		$908K Buy
56,249
+53
+0.1% +$702 ﹤0.01% 2261
2025
Q3 		$684K Buy
56,196
+3,127
+6% +$43.2K ﹤0.01% 2346
2025
Q2 		$600K Buy
53,069
+41
+0.1% +$501 ﹤0.01% 2270
2025
Q1 		$612K Sell
53,028
-80,544
-60% -$822K ﹤0.01% 2227
2024
Q4 		$1.13M Buy
133,572
+17,580
+15% +$182K ﹤0.01% 1956
2024
Q3 		$1.34M Buy
115,992
+37,310
+47% +$469K ﹤0.01% 1893
2024
Q2 		$927K Buy
+78,682
New +$918K ﹤0.01% 2001
2023
Q3 		– Sell
-1,004
Closed -$9.04K – 3574
2023
Q2 		$9.04K Hold
1,004
– – ﹤0.01% 2983
2023
Q1 		$7.89K Hold
1,004
– – ﹤0.01% 2914
2022
Q4 		$6.79K Hold
1,004
– – ﹤0.01% 2855
2022
Q3 		$14K Buy
+1,004
New +$14K ﹤0.01% 2841
2022
Q1 		– Sell
-18,705
Closed -$247K – 2849
2021
Q4 		$247K Hold
18,705
– – ﹤0.01% 2666
2021
Q3 		$326K Hold
18,705
– – ﹤0.01% 2622
2021
Q2 		$448K Hold
18,705
– – ﹤0.01% 2635
2021
Q1 		$480K Sell
18,705
-3,781
-17% -$99.3K ﹤0.01% 2540
2020
Q4 		$425K Sell
22,486
-98,467
-81% -$1.69M ﹤0.01% 2494
2020
Q3 		$1.52M Buy
+120,953
New +$1.51M ﹤0.01% 1857

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's KALV Position: Q1 2026 in Review

Russell Investments Group reduced its KalVista Pharmaceuticals (KALV) stake by 0.1% in Q1 2026, selling an estimated $919 and leaving 56,192 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

Russell Investments Group first reported a position in KALV in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.52M in Q3 2020. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Russell Investments Group held 56,192 shares of KalVista Pharmaceuticals worth $1.13M as of Q1 2026.
  • Russell Investments Group sold 57 KalVista Pharmaceuticals shares in Q1 2026, an estimated $919.
  • KalVista Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2155 holding.
  • Russell Investments Group first reported a position in KalVista Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
  • Russell Investments Group's KalVista Pharmaceuticals position peaked at $1.52M in Q3 2020.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.